{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:06:57Z","timestamp":1790100417788,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ygyno.2011.04.003","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T21:42:04Z","timestamp":1304372524000},"page":"260-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of estradiol\u2013progestin therapy associates with increased risk for uterine sarcomas"],"prefix":"10.1016","volume":"122","author":[{"given":"Susanna","family":"Jaakkola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli K.","family":"Lyytinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Pukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavi","family":"Ylikorkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.04.003_bb0005","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/gme.0b013e3181d0f6b9","article-title":"Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society","volume":"17","author":"The North American Menopause Society","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2009-2509","article-title":"Postmenopausal therapy: An Endocrine Society scientific statement","volume":"95","author":"Santen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmi028","article-title":"Breast cancer risk with postmenopausal hormone treatment","volume":"111","author":"Collins","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cncr.23956","article-title":"Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin","volume":"115","author":"Pearce","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The postmenopausal estrogen\/progestin interventions","volume":"275","author":"Judd","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0030","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Million women study. Endometrial cancer and hormone-replacement therapy in the million women study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"issue":"139","key":"10.1016\/j.ygyno.2011.04.003_bb0035","first-page":"e1","article-title":"Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer","volume":"197","author":"Doherty","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0040","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/AOG.0b013e3181bea950","article-title":"Nationwide study on endometrial cancer in postmenopausal women using estradiol\u2013progestin therapy","volume":"114","author":"Jaakkola","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: A review","volume":"116","author":"D'Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0055","first-page":"717","article-title":"Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus","author":"Schwartz","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2007.06.011","article-title":"The management of patients with uterine sarcoma: A debated clinical challenge","volume":"65","author":"Gadducci","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0065","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1054\/bjoc.1999.1038","article-title":"Expression of estrogen and progesterone receptors in low-grade endometrial stromal sarcomas","volume":"82","author":"Reich","year":"2000","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e31818e8cd6","article-title":"Breast cancer risk in postmenopausal women using estradiol\u2013progestogen therapy","volume":"113","author":"Lyytinen","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/02841869409098430","article-title":"Data quality and quality control of a population-based cancer registry. Experience in Finland","volume":"33","author":"Teppo","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/140349489402200209","article-title":"Regional variation in surgical procedure rates in Finland","volume":"22","author":"Keskimaki","year":"1994","journal-title":"Scand J Soc Med"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0085","unstructured":"International classification of diseases for oncology. Third Edition. 2000. World Health Organization. Geneva."},{"key":"10.1016\/j.ygyno.2011.04.003_bb0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2009.10.050","article-title":"The new FIGO staging system for cancers of vulva, cervix, endometrium and sarcomas","volume":"115","author":"Mutch","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0095","series-title":"Modern epidemiology","author":"Rothman","year":"1998"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0100","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1038\/sj.bjc.6601763","article-title":"Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953\u20132010","volume":"90","author":"Luoto","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001703-200402000-00002","article-title":"Uterine sarcomas: Have we made any progress?","volume":"16","author":"Omera","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0110","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2002.20.11.2758","article-title":"Association of tamoxifen and uterine sarcoma","volume":"20","author":"Wickerham","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5122(99)00027-4","article-title":"Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland","volume":"32","author":"Topo","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0120","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/cncr.20521","article-title":"Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma","volume":"101","author":"Leitao","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0125","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0090-8258(03)00258-0","article-title":"Low-grade endometrial stromal sarcoma: Hormonal aspects","volume":"90","author":"Chu","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.04.003_bb0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ygyno.2005.11.010","article-title":"Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: Single center experience with 10 cases and review of the literature","volume":"101","author":"Pink","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:27:05Z","timestamp":1758770825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0090825811002630"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.04.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of estradiol\u2013progestin therapy associates with increased risk for uterine sarcomas","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}